Basic & Clinical Medicine ›› 2022, Vol. 42 ›› Issue (7): 1129-1133.doi: 10.16352/j.issn.1001-6325.2022.07.1129
• Mini Reviews • Previous Articles Next Articles
XU Juan, LI Ye*
Received:
2021-10-28
Revised:
2022-05-07
Online:
2022-07-05
Published:
2022-06-29
Contact:
* liye918@gmail.com
CLC Number:
XU Juan, LI Ye. Research progress on the role of ferroptosis in Alzheimer's disease[J]. Basic & Clinical Medicine, 2022, 42(7): 1129-1133.
[1] | The Alzheimer's Association. 2021 Alzheimer's disease facts and figures[J]. Alzheimers Dement, 2021, 17: 327-406. |
[2] | Gerrits E, Brouwer N, Kooistra SM, et al. Distinct amyloid-β and tau-associated microglia profiles in Alzheimer's disease[J]. Acta Neuropathol, 2021, 141: 681-696. |
[3] | 张研, 魏来. APPswe/PS1dE9双转基因小鼠中轴突异常与阿尔茨海默病的联系[J].基础医学与临床, 2019, 39: 1525-1529. |
[4] | Riegman M, Sagie L, Galed C, et al. Ferroptosis occurs through an osmotic mechanism and propagates independently of cell rupture[J]. Nat Cell Biol, 2020, 22: 1042-1048. |
[5] | Huang L, McClatchy DB, Maher P, et al. Intracellular amyloid toxicity induces oxytosis/ferroptosis regulated cell death[J]. Cell Death Dis, 2020, 11: 828. doi: 10.1038/s41419-020-03020-9. |
[6] | Bao WD, Pang P, Zhou XT, et al. Loss of ferroportin induces memory impairment by promoting ferroptosis in Alzheimer's disease[J]. Cell Death Differ, 2021, 28: 1548-1562. |
[7] | Ayton S, Wang Y, Diouf I, et al. Brain iron is associated with accelerated cognitive decline in people with Alzheimer pathology[J]. Mol Psychiatry, 2020, 25: 2932-2941. |
[8] | Stockwell BR, Jiang X, Gu W. Emerging mechanisms and disease relevance of ferroptosis[J]. Trends Cell Biol, 2020, 30: 478-490. |
[9] | Butterfield DA. Brain lipid peroxidation and alzheimer disease: synergy between the Butterfield and Mattson laboratories[J]. Ageing Res Rev, 2020, 64: 101049. doi:10.1016/j.arr.2020.101049. |
[10] | Han J, Park H, Maharana C, et al. Alzheimer's disease-causing presenilin-1 mutations have deleterious effects on mitochondrial function[J]. Theranostics, 2021, 11: 8855-8873. |
[11] | Wang C, Cai X, Wang R, et al. Neuroprotective effects of verbascoside against Alzheimer's disease via the relief of endoplasmic reticulum stress in Abeta-exposed U251 cells and APP/PS1 mice[J]. J Neuroinflammation, 2020, 17: 309. doi: 10.1186/s12974-020-01976-1. |
[12] | Kapralov AA, Yang Q, Dar HH, et al. Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death[J]. Nat Chem Biol, 2020, 16: 278-290. |
[13] | Reis J, Massari M, Marchese S, et al. A closer look into NADPH oxidase inhibitors: validation and insight into their mechanism of action[J]. Redox Biol, 2020, 32: 101466. doi: 10.1016/j.redox.2020.101466. |
[14] | Park MW, Cha HW, Kim J, et al. NOX4 promotes ferroptosis of astrocytes by oxidative stress-induced lipid peroxidation via the impairment of mitochondrial metabolism in Alzheimer's diseases[J]. Redox Biol, 2021, 41: 101947. doi: 10.1016/j.redox.2021.101947. |
[15] | Ates G, Goldberg J, Currais A, et al. CMS121, a fatty acid synthase inhibitor, protects against excess lipid peroxidation and inflammation and alleviates cognitive loss in a transgenic mouse model of Alzheimer's disease[J]. Redox Biol, 2020, 36: 101648. doi: 10.1016/j.redox.2020.101648. |
[16] | Miyake S, Murai S, Kakuta S, et al. Identification of the hallmarks of necroptosis and ferroptosis by transmission electron microscopy[J]. Biochem Biophys Res Commun, 2020, 527: 839-844. |
[17] | Floros KV, Cai J, Jacob S, et al. MYCN-amplified neuroblastoma is addicted to iron and vulnerable to inhibition of the system Xc-/glutathione axis[J]. Cancer Res, 2021, 81: 1896-1908. |
[18] | Ashraf A, Jeandriens J, Parkes HG, et al. Iron dyshomeostasis, lipid peroxidation and perturbed expression of cystine/glutamate antiporter in Alzheimer's disease: evidence of ferroptosis[J]. Redox Biol, 2020, 32: 101494. doi: 10.1016/j.redox.2020.101494. |
[19] | Zhang Y, Swanda RV, Nie L, et al. mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation[J]. Nat Commun, 2021, 12: 1589. doi: 10.1038/s41467-021-21841-w. |
[20] | Zhang HL, Hu BX, Li ZL, et al. PKCβⅡ phosphorylates ACSL4 to amplify lipid peroxidation to induce ferroptosis[J]. Nat Cell Biol, 2022, 24: 88-98. |
[21] | Gleason A, Bush AI. Iron and ferroptosis as therapeutic targets in Alzheimer's disease[J]. Neurotherapeutics, 2021, 18: 252-264. |
[22] | Zuo Y, Xie J, Li X, et al. Ferritinophagy-mediated ferroptosis involved in paraquat-induced neurotoxicity of dopaminergic neurons: implication for neurotoxicity in PD[J]. Oxid Med Cell Longev, 2021, 2021: 9961628. doi: 10.1155/2021/9961628. |
[23] | Doll S, Freitas FP, Shah R, et al. FSP1 is a glutathione-independent ferroptosis suppressor[J]. Nature, 2019, 575: 693-698. |
[24] | Kraft VAN, Bezjian CT, Pfeiffer S, et al. GTP cyclohydrolase 1/tetrahydrobiopterin counteract ferroptosis through lipid remodeling[J]. ACS Cent Sci, 2020, 6: 41-53. |
[25] | Mao C, Liu X, Zhang Y, et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer[J]. Nature, 2021, 593: 586-590. |
[1] | XIAO Yanhong, JIANG Mingdong, LIN Yeyuan, RAN Can, LIANG Bo. Scutellarin inhibits proliferation and migration of human prostate cancer cell line PC-3 [J]. Basic & Clinical Medicine, 2024, 44(9): 1229-1235. |
[2] | XIAO Yanxin, LIU Yan, XU Lingling, ZHOU Yaru. Research progress on the role of ferroptosis in the pathogenesis of non-alcoholic fatty liver disease [J]. Basic & Clinical Medicine, 2024, 44(2): 260-264. |
[3] | . Role of TERT in regulating mitochondrial oxidative stress in diseases [J]. Basic & Clinical Medicine, 2024, 44(10): 1436-1441. |
[4] | SUN Lijie, HAO Dandan. Progress of researches on inducing hepatic stellate cell ferroptosis for treatment of liver fibrosis [J]. Basic & Clinical Medicine, 2024, 44(1): 108-113. |
[5] | LI Xiang, LI Ye. Research progress on the interaction between autophagy and ferroptosis in non-alcoholic fatty liver disease [J]. Basic & Clinical Medicine, 2023, 43(8): 1294-1298. |
[6] | HAO Dandan, ZHANG Lei, BAI Chunying. Research progress of drugs targeting ferroptosis for the treatment of non-alcoholic fatty liver disease [J]. Basic & Clinical Medicine, 2023, 43(8): 1317-1321. |
[7] | CHU Xiaoyun, CAI Cheng. Research progress on the mechanism of ferroptosis in neonatal acute lung injury [J]. Basic & Clinical Medicine, 2023, 43(6): 1008-1011. |
[8] | YAN Lin, LU Juexiu, LUO Ying, LIU Xianxia. Protective effect of BM-MSCs-derived exosome-mediated ferroptosis against anoxia-reoxygenation injury in rat cardiomyoblastl cell line H9c2 [J]. Basic & Clinical Medicine, 2023, 43(5): 771-776. |
[9] | XIANG Caixia, HUANG Bintao, HAO Jian. Research progress of anti-apoptotic inhibitor venetoclax in treatment of myeloid leukemia [J]. Basic & Clinical Medicine, 2023, 43(5): 833-836. |
[10] | QU Dapeng, SUN Huiyan, LI Qiang, WANG Hongquan. Recent progress of the role of ferroptosis in the pathogenesis of early brain injury after subarachnoid hemorrhage [J]. Basic & Clinical Medicine, 2023, 43(3): 486-489. |
[11] | ZHUANG Zhicheng, GUAN Guoxian. Ferroptosis in the treatment of colorectal cancer [J]. Basic & Clinical Medicine, 2023, 43(1): 174-177. |
[12] | XUE Jin-fang, SONG Hai-fei, CHEN Guo-bing. Research progress of programmed cell death in the occurrence and development of sepsis [J]. Basic & Clinical Medicine, 2022, 42(8): 1284-1287. |
[13] | WANG Feng-yu, LI Gen, LIN Xiao-yi, YAO Xin-yue, CHEN Yu. Research progress on the role of ferroptosis in the treatment of tumors [J]. Basic & Clinical Medicine, 2022, 42(11): 1781-1784. |
[14] | XU Fei, CHEN Wei-da, GUO Ming-hao, CHEN Ze-tao. Progress of ferroptosis mechanism and application in lung cancer therapy [J]. Basic & Clinical Medicine, 2021, 41(3): 442-447. |
Viewed | ||||||||||||||||||||||||||||||||||||||||||||||||||
Full text 545
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Abstract 456
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||